News

Becton, Dickinson and Company: It's Wait And See For Me
Becton, Dickinson and Company has struggled over the past decade, with a 10-year CAGR of only 5.1%. Read what keeps me on the ...
Becton Dickinson price target lowered to $260 from $280 at Piper Sandler
Piper Sandler analyst Jason Bednar lowered the firm’s price target on Becton Dickinson to $260 from $280 and keeps an Overweight rating on the ...
Analysts Offer Insights on Healthcare Companies: Becton Dickinson (BDX), Intuitive Surgical (ISRG) and Century Therapeutics (IPSC)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Becton Dickinson (BDX – Research Report), ...
Becker's Hospital Review4d
FDA issues safety alert for BD catheters
The FDA has issued a safety warning regarding a potentially high-risk issue involving certain BD PowerPICC Intravascular Catheters. The affected devices are 4 Fr. Single Lumen PowerPICC catheters, ...